PARP is a family of proteins involved in a number of cellular processes involving mainly DNA repair and programmed cell death.The PARP family consists of 17 individuals. They are all very different in terms of their cell structures and functions. There is confirmed PARP activity in the following proteins: PARP1, PARP2, VPARP (PARP4), Tankyrase-1 and -2 (PARP-5a or TNKS, and PARP-5b or TNKS2). Additional genes include PARP3, TIPARP (or PARP7), PARP8, PARP9, PARP10, PARP11, PARP12, PARP14, PARP15, and PARP16. The nucleus of the cell contains PARP. The primary responsibility is to identify and alert the enzymatic machinery responsible for SSB repair to single-strand DNA breaks (SSB).
| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V110790 | PARP1 degrader 1 | PARP1 degrader 1 (compound 2c) is a relatively effective PARP1 HyT degrader (the intracellular DC50 of PARP-1 is 618 nM). | |
|
V80290 | PARP1-IN-15 | PARP1-IN-15 (Compound 6) is a PARP1 inhibitor. | |
|
V81047 | PARP1-IN-16 | PARP1-IN-16 (compound 12a) is a potent PARP1 inhibitor (antagonist) with IC50 of 1.89 nM. | |
|
V79059 | PARP1-IN-17 | PARP1-IN-17 is a PARP-1 inhibitor (PARP-1 IC50 = 19.24 nM, PARP-2 IC50 = 32.58 nM) and can cause apoptosis. | |
|
V85166 | PARP1-IN-18 | 2958609-64-6 | |
|
V84889 | PARP1-IN-19 | 2756337-27-4 | |
|
V88726 | PARP1-IN-20 | 2659357-95-4 | PARP1-IN-20 (compound 19A10) is a potent inhibitor of PARP1 with IC50 of 4.62 nM and has similar low PARP trapping effect compared to Veliparib, IC50 (MDA-MB-436) >100 μM. |
|
V88734 | PARP1-IN-21 | 2855979-51-8 | PARP1-IN-21 (example 16) is a potent inhibitor of PARP1 with IC50 of < 10 nM. |
|
V88731 | PARP1-IN-22 | 3033649-17-8 | PARP1-IN-22 (compound 15) is a potent inhibitor of PARP1 with IC50 of < 10 nM. |
|
V99611 | PARP1-IN-28 | 2855059-11-7 | PARP1-IN-28 (Compound 1) is an inhibitor of PARP1. |
|
V96683 | PARP1-IN-29 | 1567375-93-2 | PARP1-IN-29 is an oral PARP-1 inhibitor with IC50 of 6.3 nM. |
|
V96674 | PARP1-IN-30 | 908803-38-3 | PARP1-IN-30 (compound 3) is a specific and potent PARP1 inhibitor with cytotoxicity. |
|
V104017 | PARP1-IN-33 | 2640677-68-3 | PARP1-IN-33 (Example 6) is a PARP1 inhibitor (IC50: 0.41 nM). |
|
V104555 | PARP1-IN-35 | PARP1-IN-35 (compound T26) is a selective, orally active, blood-brain permeable PARP1 inhibitor with IC50 values of 0.2 and 122 nM for PARP1 and PARP2, respectively. | |
|
V119614 | PARP1-IN-42 | 3066444-12-7 | PARP1-IN-42 (Example 43 cis-a) is a PARP1 inhibitor with an IC50 <10 nM. |
|
V119366 | PARP1-IN-43 | 3066798-40-8 | PARP1-IN-43 (compound 5350) is a PARP1 inhibitor that can cross the blood-brain barrier (BBB) with an IC50 value of 5 nM. |
|
V117577 | PARP1-IN-44 | PARP1-IN-44 is an olaparib derivative, an orally effective PARP1 inhibitor (IC50 = 0.6 nM), which also inhibits PARP2 (IC50 = 1.0 nM) and PARP7 (IC50 = 7.5 nM). | |
|
V117740 | PARP1-IN-45 | PARP1-IN-45 (compound 15) is a PARP1 inhibitor with an IC50 of 17 nM. | |
|
V117590 | PARP1-IN-46 | 2505146-00-7 | PARP1-IN-46 is a potent PARP-1 inhibitor with an IC50 value of 2.4 nM. |
|
V116529 | PARP1-IN-47 | 3053592-61-0 | PARP1-IN-47 (compound 35) is a highly selective PARP1 inhibitor (IC50 <100 nM). |